<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:6pt Arial, sans-serif; }
 .font1 { font:7pt Arial, sans-serif; }
 .font2 { font:8pt Arial, sans-serif; }
 .font3 { font:11pt Arial, sans-serif; }
 .font4 { font:14pt Arial, sans-serif; }
 .font5 { font:10pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font4">J.P. Morgan</span></p>
<p><span class="font2" style="font-weight:bold;">Asia Pacific Equity Research</span></p>
<p><span class="font1" style="font-weight:bold;">07 September 2016</span></p>
<p><span class="font1" style="font-weight:bold;">Isabella Y. Zhao, CFA</span></p>
<p><span class="font1" style="font-weight:bold;">(852) 2800-8534</span></p>
<p><a href="mailto:isabella.zhao@jpmorgan.com"><span class="font1" style="font-weight:bold;">isabella.zhao@jpmorgan.com</span></a></p>
<p><a name="bookmark0"></a><span class="font3" style="font-weight:bold;"><a name="bookmark1"></a>Balance sheet and cash flow</span></p>
<p><span class="font5" style="font-weight:bold;">Declining capex and healthy Cash Flow</span></p>
<p><span class="font5">Fosun’s capex as a % of revenue increased to 9.9% in the 2015, up from 9.4% in 2014. In 1H16, Fosun had a capital expenditure worth RMB888mn up from RMB476mn in 1H15. This was primarily due to a significant increase in the capex in pharmaceutical manufacturing and R&amp;D segment. We expect this number to go down further to 6.6%, 5.5% and 3.7% in 2016, 2017 and 2018.</span></p>
<p><span class="font5">Fosun also has a healthy operating cash flow of Rmb l,354mn in 2015, almost double of the 2014 amount. In 1H16, the operating cash flow was RMB936mn as compared to RMB677mn in 1H15. The cash flow is expected to grow to Rmb 3,494mn in 2016, Rmb 3,15 8mn in 2017 and Rmb 3,81 Imn in 2018. Fosun also has a health cash and equivalents of Rmb 4,028 mn in 2015. This number is expected to increase in the next period to Rmb5,924mn in 2016, Rmb 9,117mn in 2017 and Rmb 12,858mn in 2018.</span></p>
<div>
</div><br clear="all">
<p><span class="font1" style="font-weight:bold;">22</span></p>
</body>
</html>